Dermatology
Conference Coverage
Meta-analysis examines cancer risk concern for JAK inhibitors
Although no increased cancer risk was seen vs. methotrexate or placebo, Janus kinase inhibitors were associated with a higher cancer risk than...
Latest News
Small study finds IPL-radiofrequency combination effective for dry eye disease
In the study of 11 patients, meibomian gland expression and meibum quality improved in all eyelids after treatment.
Conference Coverage
Guidelines for assessing cancer risk may need updating
Whole-exome sequencing reveals cancer risk mutations in patients that would not have qualified for testing based on current guidelines.
From the Journals
Study focuses on adolescent data in upadacitinib AD trials
Upadacitinib was generally well tolerated among the adolescents, with mild or moderate acne being the most common adverse event.
Conference Coverage
‘Exciting’ results for cancer vaccine plus pembro in melanoma
A new randomized study is the first to demonstrate improvement in recurrence-free survival in melanoma with an individualized neoantigen vaccine...
Latest News
USPSTF releases updated recommendations on skin cancer screening
“Our recommendations are for patients who present to primary care without symptoms, and after a careful assessment of benefit and harms, we didn’t...
Latest News
Study compares noninvasive treatments of cutaneous neurofibromas
The epidermis overlying cNF is normal, “so there is no reason to use nonselective or surgical methods and destroy a perfectly good epidermis when...
Latest News
Study suggests narrow excision margins safe in early melanoma resection
There were no significant differences in 10-year local recurrence rates or melanoma-specific mortality following excision with 5 mm vs. 10 mm...
Latest News
What happens to melanocytic nevi during laser hair removal?
“It’s important to keep an eye out for changes and always be evaluating,” Dr. Ahuva Cices said.
From the Journals
Alzheimer’s drug may ease hair pulling, skin-picking disorders
Behavioral therapy that attempts to reverse these habits is considered first-line treatment, but trained therapists are difficult to find.
Latest News
FDA clears first patch to treat axillary hyperhidrosis
Patients experienced a reduction in sweat that was maintained for 3 months or longer, according to trial results.